Head and Neck Cancer

Head and neck cancer refers to a group of cancers that occur in the head and neck region, including the pharynx, nasal cavity, larynx, oral, and salivary glands. Alfa Cytology is a world leader in the research of cancer. With our extensive experience and advanced technology platform, we can provide the best solutions for head and neck cancer.

Introduction to Head and Neck Cancer

Head and neck cancer is the sixth most common cancer worldwide. Cancers can often be classified according to structure or cell type. In addition, head and neck cancer is often associated with risk factors such as smoking and alcohol consumption, human papillomavirus (HPV) infection, and exposure to certain chemicals and pollutants.

Targets of Head and Neck Cancer Therapy Development

Many experimental data show that head and neck cancer has specific molecular targets, which can be used for therapeutic purposes. Some common targets for head and neck cancer are shown in the table below.

Epidermal Growth Factor Receptor (EGFR)
Fibroblast Growth Factor Receptor (FGFR)

Programmed Cell Death Protein 1 (PD-1)
Human Papillomavirus (HPV)

Therapy for Head and Neck Cancer

Therapy for head and neck cancer depends on a variety of factors, including the site and stage of the disease, overall health, and personal preference. Advancing the understanding and cure of head and neck cancer still needs continued research and development efforts. New therapies are also being developed through the continuous progress of bioengineering methods development.

Therapies	Description
Immunotherapy	Immune checkpoint inhibitors, as a type of immunotherapy, have shown some success in treating recurrent or metastatic head and neck cancer. They work by blocking proteins such as PD-1 or PD-L1. In addition, some other immunotherapies are under development.
Combination therapy	Researchers are exploring the effectiveness of combining different therapy modalities, such as chemoradiotherapy with targeted therapy or immunotherapy, to improve outcomes and reduce recurrence rates.

Our Services

Various classifications of head and neck cancers are often named after the specific region in which they originate, and different types of cells may be involved. Therefore, Alfa Cytology is working on providing one-stop solutions for types of head and neck cancer, including but not limited to the following.

Hypopharyngeal Cancer

Laryngeal Cancer

Oral Cancer

Nasal and Sinus Cancer

Nasopharyngeal Cancer

Salivary Gland Cancer

Alfa Cytology is committed to the research and study of cancer, from molecular biology services, and cancer biomarker discovery services, to preclinical research services, providing one-stop services. Our cancer experts have many years of experience in the development of the latest therapies for head and neck cancer. If you are interested in our service, please contact us.

For research use only.